Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the nasal inhalation of Gernebcin® is
effective to decrease the Pseudomonas aeruginosa bacterial count in the nasal lavage fluid.